-
Recent Posts
Archives
Categories
Meta
Tag Archives: $RXII
Thoughts, six months later
Whoa, what happened out in UC-Davis? Pepper spraying students protesting peacefully? Not right. OK, back to some fun. A half-year. Six-months. 184 days. More grey hairs. This has been a fun experiment. Once a week (or so), I jot down … Continue reading
No respect for RNAi ($RXII)
RNAi must feel like Rodney Dangerfield – it gets no respect. Back in 1998, RNAi was hot. It was so hot that just 8 years later, Andrew Fire and Craig Mello, received the Nobel Prize in Physiology or Medicine for … Continue reading
$CYTR: $INNO and out with chaperones
It has been an interesting couple of years for $CYTR. Their lead asset heading into 2008 was arimoclomol, a small molecule thought to activate Hsp70, which was placed on clinical hold (January 2008) over potential toxicology concerns in rats. While … Continue reading
Posted in Jewel in the rough?
Tagged $CYTR, $INNO, $RXII, biotech, neurodegenerative, oncology
1 Comment
Sell in May, and go away?
While some investors might heed the “Sell in May, and go away” mantra, if you’re a little guy looking for ideas in biotech, going away in June is probably more realistic. Better for me, as it coincides with the end … Continue reading